<body><script type="text/javascript"> function setAttributeOnload(object, attribute, val) { if(window.addEventListener) { window.addEventListener('load', function(){ object[attribute] = val; }, false); } else { window.attachEvent('onload', function(){ object[attribute] = val; }); } } </script> <div id="navbar-iframe-container"></div> <script type="text/javascript" src="https://apis.google.com/js/platform.js"></script> <script type="text/javascript"> gapi.load("gapi.iframes:gapi.iframes.style.bubble", function() { if (gapi.iframes && gapi.iframes.getContext) { gapi.iframes.getContext().openChild({ url: 'https://www.blogger.com/navbar/5621345630369022014?origin\x3dhttps://cderwn.blogspot.com', where: document.getElementById("navbar-iframe-container"), id: "navbar-iframe" }); } }); </script>

Drug Evaluation & Research

CDERNEW-TEXT 10/15/2007


Tuesday, October 16, 2007

October 15, 2007

FDA Acronyms Search
http://www.accessdata.fda.gov/scripts/cder/acronyms/index.cfm

(updated)


New and Generic Drug Approvals
http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm

Delestrogen (estradiol valerate) Injection, JHP Pharma, Manufacturing
Change or Addition

Doribax (doripenem) Injection, Johnson & Johnson, Approval

Isentress (raltegravir) Tablets, Merck & Co., Approval

Januvia (sitagliptin) Tablets, Merck & Co., New or Modified Indication

LEXIVA (fosamprenavir calcium; FPV) Oral Tablets, GlaxoSmithKline, New
Dosage Regimen

Lodine (etodolac) Capsules and Tablets, Wyeth Pharma, Labeling Revision

Nateglinide Tablets, Watson Labs, Tentative Approval

Oxcarbazepine Tablets, Apotex, Tentative Approval

------------------------------------------------
To subscribe or to unsubscribe from CDERNEW-TEXT

http://list.nih.gov/archives/cdernew-text.html
------------------------------------------------

posted by Mags @ 5:09 AM,




0 Comments:

Post a Comment

<< Home